Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide effect on emphysema progression in smokers
NCT00232674Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and emphysema comparing Budesonide with Placebo (2 arms). Primary endpoint: Change in lung density measured by Computed Tomography (PD15) at 4 years. Started Jul 1999; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)emphysema
Beyond the preview
Go deeper on NCT00232674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232674.